SUBSCRIBE
SUBSCRIBE
News   FDA

AstraZeneca PLC’s Seroquel XR Gets EC Approval

September 3, 2010 | 
1 min read
LONDON (Reuters) - Drugmaker AstraZeneca (AZN.L) said on Thursday the European Commission had approved Seroquel XR as an add-on treatment for major depressive disorder for patients that had not responded well to an existing antidepressant
FDA Approvals Europe
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong
FDA Headquarters_Grandbrothers/Adobe Stock
Policy
Former CBER Chief Marks Decries New FDA COVID-19 Framework
June 26, 2025
 · 
3 min read
 · 
Tristan Manalac
Finding Talent. Big Hands with Magnifying Glass Recruiting People. vector
Duchenne muscular dystrophy
FDA Reviews Sarepta’s Elevidys After Second Patient Death
June 25, 2025
 · 
2 min read
 · 
Tristan Manalac
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
FDA
FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open
June 25, 2025
 · 
2 min read
 · 
Tristan Manalac